# Prenetics acquires Oxsed for rapid Covid-19 testing technology

DNAFit, a subsidiary of Prenetics, has acquired Oxsed, an Oxford University spinout that developed the RaVID Direct Covid-19 test kit, gaining exclusive global rights to the technology.

- Type: Acquisition
- Announced: 2020-11-02
- Status: completed
- Products: RaVID Direct Covid-19 test kit
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Prenetics](https://endata.com/companies/50911.md) (acquirer)
- [Oxsed](https://endata.com/companies/50912.md) (target)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/uncategorized/54293/), 2020-11-02: "DNAFit and Prenetics now have exclusive global rights to Oxsed technologies."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.